Cyclin D1 and human neoplasia.
Neoplasia is characterised by abnormal regulation of the cell cycle. Cyclin D1 is a protein derived from the PRAD1, CCND1 or bcl-1 gene on chromosome 11q13, which is involved in both normal regulation of the cell cycle and neoplasia. In the G1 (resting) phase of the cell cycle, cyclin D1 together with its cyclin dependent kinase (cdk) partner, is responsible for transition to the S (DNA synthesis) phase by phosphorylating the product of the retinoblastoma gene (pRB), which then releases transcription factors important in the initiation of DNA replication. Amplification of the CCND1 gene or overexpression of the cyclin D1 protein releases a cell from its normal controls and causes transformation to a malignant phenotype. Analysis of these changes provides important diagnostic information in mantle cell (and related) lymphomas, and is of prognostic value in many cancers. Knowledge of cyclin D1's role in malignancy at the various sites, provides a basis on which future treatment directed against this molecule can proceed.
Donnellan
R
R
Department of Pathology, University of Natal Medical School, Durban, South Africa. donnellanr@med.und.ac.za
Chetty
R
R
D014408:Biomarkers, Tumor / Q000378:metabolism*; D002453:Cell Cycle / Q000502:physiology; D019938:Cyclin D1 / Q000378:metabolism*; D019940:Genes, bcl-1; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism*; D009369:Neoplasms / Q000235:genetics / Q000378:metabolism*; D016160:Retinoblastoma Protein / Q000378:metabolism
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D016160:Retinoblastoma Protein; D019938:Cyclin D1